[ [PMID: 30026333] [ [PMID: 35230650] [ [PMID: 35813188] [ [PMID: 36510488] versus GLP-1 RAs in patients with type 2 diabetes previously receiving 12 oral antidiabetics: Systematic review and network meta-analysis
Together these data indicate that although vagal afferent neurons may contribute to hypophagia induced by peripheral administration of GLP-1R analogs, these neurons are not necessary for the hypophagic effect
The idea that modern bariatric surgery is defined by horrific complications or widespread TPN dependence is simply inaccurate
Heavyweight battle The lawsuit comes as pharmaceutical heavyweights Novo and Eli Lilly are locked in battle to dominate the fast-growing weight-loss drug industry, especially in the US, which analysts have estimated could be worth more than $100bn by 2030
Screenshot 2025-08-18 at 7.29.53 PM738210 12.1 KB After 12 weeks of treatment with amycretin up to 50 mg and up to 2x 50 mg, participants achieved a mean change in body weight of -10.4% and -13.1% respectively, compared to -1.2% with placebo
[DOI] [PubMed] [Google Scholar] 245.Parente E., Colannino G., Picconi O., Monastra G
